Etanercept in the treatment of rheumatoid arthritis.

Ther Clin Risk Manag · 2007 · PMC1936291 · PMID 18360618

Europe PMC DOI

hedged sentence

0.0670

closest p · 1.3× alpha

0.0670

boldest claim

The sentences

showed a trendp=0.067so close (0.05 < p ≤ 0.1)

Safety analysis of the trials showed a trend (p=0.067) toward more overall infections in the ETN-treated patients versus placebo in one of the trials, but not in the second one.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.